Dr. Cipto Mangunkusumo National Central Public Hospital, is a government run hospital located at Salemba in Jakarta, Indonesia.

During the past decade, Cipto Mangunkusumo Hospital conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cipto Mangunkusumo Hospital" #1 sponsor was "Indonesia University" with 80 trials, followed by "Fakultas Kedokteran Universitas Indonesia" with 7 trials sponsored, "Dr.dr.Irma Bernadette, SpKK (K)" with 4 trials sponsored, "Ahmad Jabir Rahyussalim" with 3 trials sponsored and "Dr Cipto Mangunkusumo General Hospital" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cipto Mangunkusumo Hospital" #1 collaborator was "Dr Cipto Mangunkusumo General Hospital" with 8 trials as a collaborator, "Fakultas Kedokteran Universitas Indonesia" with 5 trials as a collaborator, "Binus University International" with 2 trials as a collaborator, "Asan Medical Center" with 1 trials as a collaborator and "Astellas Pharma Indonesia Inc." with 1 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Cipto Mangunkusumo Hospital" are "Sepsis" (4 trials), "Analgesia" (3 trials), "COVID-19" (3 trials), "ADHD" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Cipto Mangunkusumo Hospital" in a lesser frequency.

Most popular intervention types in "Cipto Mangunkusumo Hospital" are "Drug" (43 trials), "Other" (29 trials), "Procedure" (19 trials), "Biological" (8 trials) and "Device" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Dexamethasone" (2 trials), "placebo" (2 trials), ""One-per-mil" Tumescent Solution Injection" (1 trials) and "0.05% Tretinoin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cipto Mangunkusumo Hospital" are 101 trials for "All" genders, 14 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 28 active trials in "Cipto Mangunkusumo Hospital". 4 are not yet recruiting, 15 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 67 completed trials in Cipto Mangunkusumo Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cipto Mangunkusumo Hospital, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 56 trials that are defined as “Not Applicable".